AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+9.46%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.03B
AUM Growth
+$3.03B
(+3.1%)
Cap. Flow
+$76.1M
Cap. Flow
% of AUM
2.51%
Top 10 Holdings %
Top 10 Hldgs %
46.17%
Holding
153
New
22
Increased
19
Reduced
69
Closed
16
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$83M |
| 2 |
KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
|
$63.9M |
| 3 |
KE Holdings
BEKE
|
$53.3M |
| 4 |
IGMS
IGM Biosciences
IGMS
|
$50.8M |
| 5 |
iTeos Therapeutics
ITOS
|
$27M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$42.9M |
| 2 |
PayPal
PYPL
|
$34.8M |
| 3 |
Avantor
AVTR
|
$34M |
| 4 |
argenx
ARGX
|
$33M |
| 5 |
Zillow
Z
|
$28.7M |
Sector Composition
| 1 | Healthcare | 78.37% |
| 2 | Consumer Discretionary | 13.95% |
| 3 | Technology | 3.4% |
| 4 | Real Estate | 1.76% |
| 5 | Materials | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRVL
101
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $3.08M | 0.07% | 302,750 -67,250 | -18% | -$685K |
|
102
Merus
MRUS
$4.98B
| $3M | 0.07% | 250,000 -134,000 | -35% | -$1.61M |
|
103
Zentalis Pharmaceuticals
ZNTL
$122M
| $2.86M | 0.07% | 87,400 -4,600 | -5% | -$150K |
|
104
Protagonist Therapeutics
PTGX
$3.67B
| $2.6M | 0.06% | 133,000 -7,000 | -5% | -$137K |
|
|
EVLO
105
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $2.5M | 0.06% | 475,000 -191,666 | -29% | -$1.01M |
|
106
Minerva Neurosciences
NERV
$16.5M
| $2.42M | 0.06% | 760,000 -40,000 | -5% | -$127K |
|
107
MEI Pharma
MEIP
$160M
| $2.37M | 0.06% | 760,000 +46,000 | +6% | +$144K |
|
|
KDNY
108
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.19M | 0.05% | 902,500 -47,500 | -5% | -$115K |
|
|
PAND
109
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| $1.66M | 0.04% | +145,000 | New | +$1.66M |
|
110
Curis
CRIS
$20.9M
| $1.64M | 0.04% | 1,404,729 -73,933 | -5% | -$86.5K |
|
|
CHMA
111
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $1.63M | 0.04% | +380,000 | New | +$1.63M |
|
112
Adicet Bio
ACET
$59.9M
| $1.54M | 0.04% | 129,335 -823,665 | -86% | -$9.79M |
|
|
ORTX
113
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $1.45M | 0.04% | 351,500 -18,500 | -5% | -$76.1K |
|
114
CytomX Therapeutics
CTMX
$336M
| $1.19M | 0.03% | 178,600 -9,400 | -5% | -$62.5K |
|
|
BLU
115
DELISTED
BELLUS Health Inc.
BLU
| $1.08M | 0.03% | 475,000 +331,237 | +230% | +$752K |
|
116
Ironwood Pharmaceuticals
IRWD
$214M
| $994K | 0.02% | 110,532 | – | – |
|
117
Rigel Pharmaceuticals
RIGL
$697M
| $771K | 0.02% | 321,100 -16,900 | -5% | -$40.6K |
|
118
Cidara Therapeutics
CDTX
$1.66B
| $640K | 0.02% | 224,675 -11,825 | -5% | -$33.7K |
|
119
Passage Bio
PASG
$22.7M
| $205K | 0.01% | 15,648 -218,352 | -93% | -$2.86M |
|
120
CryoPort
CYRX
$444M
| – | – | -89,000 | Closed | -$2.69M |
|
121
Delta Air Lines
DAL
$40.3B
| – | – | 0 | – | – |
|
122
Dianthus Therapeutics
DNTH
$759M
| – | – | -450,000 | Closed | -$3.38M |
|
123
General Motors
GM
$55.8B
| – | – | 0 | – | – |
|
124
Goldman Sachs
GS
$226B
| – | – | 0 | – | – |
|
125
Huazhu Hotels Group
HTHT
$11.3B
| – | – | -175,000 | Closed | -$6.13M |
|